National Centre for Foreign Animal Disease, Canadian Food Inspection Agency, Winnipeg R3E 3M4, Manitoba, Canada.
Department of Medical Microbiology and Infectious Diseases, College of Medicine, Faculty of Health Sciences, University of Manitoba, Winnipeg R3E 0J9, Manitoba, Canada.
Anal Chem. 2023 Jul 18;95(28):10522-10531. doi: 10.1021/acs.analchem.2c05032. Epub 2023 Jun 30.
While molecular diagnostics generally require heating elements that supply high temperatures such as 95 °C in polymerase chain reaction and 60-69 °C in loop-mediated isothermal amplification, the recently developed CRISPR-based SHERLOCK (specific high-sensitivity enzymatic reporter unlocking) platform can operate at 37 °C or a similar ambient temperature. This unique advantage may be translated into highly energy-efficient or equipment-free molecular diagnostic systems with unrestricted deployability. SHERLOCK is characterized by ultra-high sensitivity when performed in a traditional two-step format. For RNA sensing, the first step combines reverse transcription with recombinase polymerase amplification, while the second step consists of T7 transcription and CRISPR-Cas13a detection. The sensitivity drops dramatically, however, when all these components are combined into a single reaction mixture, and it largely remains an unmet need in the field to establish a high-performance one-pot SHERLOCK assay. An underlying challenge, conceivably, is the extremely complex nature of a one-pot formulation, crowding a large number of reaction types using at least eight enzymes/proteins. Although previous work has made substantial improvements by serving individual enzymes/reactions with accommodating conditions, we reason that the interactions among different enzymatic reactions could be another layer of complicating factors. In this study, we seek optimization strategies by which inter-enzymatic interference may be eliminated or reduced and cooperation created or enhanced. Several such strategies are identified for SARS-CoV-2 detection, each leading to a significantly improved reaction profile with faster and stronger signal amplification. Designed based on common molecular biology principles, these strategies are expected to be customizable and generalizable with various buffer conditions or pathogen types, thus holding broad applicability for integration into future development of one-pot diagnostics in the form of a highly coordinated multi-enzyme reaction system.
虽然分子诊断通常需要加热元件来提供高温,如聚合酶链反应中的 95°C 和环介导等温扩增中的 60-69°C,但最近开发的基于 CRISPR 的 SHERLOCK(特异性高灵敏度酶报告物解锁)平台可以在 37°C 或类似的环境温度下运行。这种独特的优势可以转化为具有高度节能或无设备、可不受限制部署的分子诊断系统。SHERLOCK 在传统的两步格式中具有超高的灵敏度。对于 RNA 检测,第一步将逆转录与重组酶聚合酶扩增相结合,第二步由 T7 转录和 CRISPR-Cas13a 检测组成。然而,当所有这些成分都组合成一个单一的反应混合物时,灵敏度会急剧下降,而在该领域建立高性能的一键式 SHERLOCK 检测仍然是一个未满足的需求。可以想象,一个潜在的挑战是一键式配方的极其复杂性质,使用至少八种酶/蛋白将大量反应类型挤在一个反应混合物中。尽管之前的工作通过提供适应条件的单个酶/反应取得了实质性的改进,但我们认为不同酶反应之间的相互作用可能是另一个复杂因素。在这项研究中,我们寻求优化策略,以消除或减少酶间干扰,并创造或增强合作。我们确定了几种用于 SARS-CoV-2 检测的策略,每种策略都显著改善了反应谱,实现了更快、更强的信号放大。这些策略基于常见的分子生物学原理设计,预计可根据各种缓冲条件或病原体类型进行定制和推广,因此在以高度协调的多酶反应系统的形式整合到未来一键式诊断的开发中具有广泛的适用性。